 JPMorgan Chase Co. boosted its position in Aldeyra Therapeutics, Inc NASDAQ:ALDX by 756.6 during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission SEC. The fund owned 63,340 shares of the biotechnology companys stock after buying an additional 55,946 shares during the period. JPMorgan ... 